Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

39.18
+0.05000.13%
Pre-market: 38.59-0.5900-1.51%08:11 EDT
Volume:3.46M
Turnover:135.03M
Market Cap:45.64B
PE:65.30
High:39.39
Open:38.93
Low:38.65
Close:39.13
52wk High:40.79
52wk Low:18.83
Shares:1.17B
Float Shares:1.09B
Volume Ratio:0.66
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:5.89
PE(LYR):32.38

Loading ...

US Appeals Court Revives Teva Lawsuit over Lilly Osteoporosis Drug

Reuters
·
Jul 14

Jefferies Keeps Their Buy Rating on Teva Pharmaceutical (TEVA)

TIPRANKS
·
Jul 10

Teva Pharmaceuticals Obtains Rights to Commercialize Polpharma's Biosimilar Candidate to Ocrevus

MT Newswires Live
·
Jul 09

Teva, Polpharma Biologics announce global licensing agreement

TIPRANKS
·
Jul 09

Teva, Samsung Bioepis Partner to Commercialize Eylea Biosimilar Opuviz in Canada

MT Newswires Live
·
Jul 09

Teva, Samsung Bioepis enter commercialization agreement for OPUVIZ

TIPRANKS
·
Jul 09

Movement Alert|Teva Pharmaceutical Industries Falls 5.17% in Regular Trading, Trading at $32.86

Market Focus
·
Jul 08

Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD), Teva Pharmaceutical (TEVA) and BridgeBio Pharma (BBIO)

TIPRANKS
·
Jul 08

Teva to advance TEV-‘408 into Phase 2b study in vitiligo in Q4

TIPRANKS
·
Jul 07

Teva - Tev-’408 Shows Improved Skin Pigmentation and no Safety Signals in Phase 1B

THOMSON REUTERS
·
Jul 07

Teva call volume above normal and directionally bullish

TIPRANKS
·
Jul 07

Teva call volume above normal and directionally bullish

TIPRANKS
·
Jul 02

Lowe’s, Kraft Heinz, Teva, Take-Two, HIVE Insider Shock

TIPRANKS
·
Jun 27

Teva Pharmaceutical Industries (TEVA) Stock Could Be 23.7% Undervalued After Recent Pullback

Simply Wall St.
·
Jun 22

FDA Seeks Updated Labeling for Testosterone Therapies

MT Newswires Live
·
Jun 19

Teva Submits New Drug Application for Ecopipam to Treat Pediatric Tourette Syndrome

MT Newswires Live
·
Jun 19

Teva submits NDA for Ecopipam to FDA

TIPRANKS
·
Jun 19

Teva Releases Q2 2026 Aide Memoire

THOMSON REUTERS
·
Jun 19

Teva - Ecopipam Showed Statistically Significant Benefit on Primary Efficacy Endpoint in Pediatric Patients

THOMSON REUTERS
·
Jun 19

Jefferies continues to like Teva after recent pullback

TIPRANKS
·
Jun 19